AirSculpt Technologies (NASDAQ: AIRS) net income
AirSculpt Technologies reported a net loss of $11.7m for fiscal 2025; in fiscal 2024 it reported a net loss of $8.0m. Earnings per share were −$0.19.
AirSculpt Technologies's best year of the last 6 was fiscal 2021. It reported a loss in 4 of those 6 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$11.7m | — | −7.7% | −$0.19 |
| 2024 | −$8.0m | — | −4.4% | −$0.14 |
| 2023 | −$4.2m | — | −2.2% | −$0.08 |
| 2022 | −$14.7m | −239.1% | −8.7% | −$0.26 |
| 2021 | $10.6m | +39.3% | 7.9% | — |
| 2020 | $7.6m | — | 12.1% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
AirSculpt Technologies net income compared with its sector
By net income for its latest fiscal year, AirSculpt Technologies ranks 194th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of AirSculpt Technologies, −7.7%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 192nd | Anika Therapeutics | −$10.9m | −9.6% |
| 193rd | AtriCure | −$11.4m | −2.1% |
| 194th | AirSculpt Technologies | −$11.7m | −7.7% |
| 195th | Anaptysbio | −$13.2m | −5.6% |
| 196th | Monopar Therapeutics | −$13.7m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of AirSculpt Technologies
- How much did AirSculpt Technologies earn in fiscal 2025?
- AirSculpt Technologies reported a net loss of $11.7m for fiscal 2025. In fiscal 2024 it reported a net loss of $8.0m.
- What are the earnings per share of AirSculpt Technologies?
- They were −$0.19 in fiscal 2025, compared with −$0.14 in fiscal 2024.
- What was the most profitable year for AirSculpt Technologies?
- Of its last 6 fiscal years, fiscal 2021, with $10.6m.
- Where does AirSculpt Technologies rank in its sector by net income?
- It ranks 194th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for AirSculpt Technologies come from?
- From the annual report (Form 10-K) that AirSculpt Technologies files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that AirSculpt Technologies files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on AirSculpt Technologies: the AirSculpt Technologies page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.